Bosuvi 400mg Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Bosutinib (400mg)
Overview Bosuvi 400mg Tablet
Bosuvi 400mg tablets are an anticancer medication indicated for treating chronic myeloid leukemia (CML), a specific type of blood cancer. This medication inhibits the proliferation and growth of cancerous cells, thereby slowing disease progression. Dosage and duration of Bosuvi 400mg tablet treatment should be determined solely by your physician. It can be administered with or without food, but consistent daily intake at a scheduled time is crucial for optimal efficacy. Abrupt cessation is strongly discouraged; continue taking the medication as prescribed. Commonly reported adverse effects include respiratory infections, nasopharyngitis, thrombocytopenia, leukopenia, anemia, cephalalgia, dyspnea, cough, elevated hepatic enzymes, diarrhea, emesis, nausea, and abdominal discomfort. Report any concerning side effects to your doctor; management strategies may be available. Immediately report severe headaches, unilateral leg edema, dyspnea on exertion, or visual/auditory disturbances. Prior to initiating Bosuvi 400mg tablet therapy, disclose all pre-existing medical conditions and concomitant medications to your physician. This medication is contraindicated in pregnant and breastfeeding individuals due to potential harm to the fetus.
Primary Ingredients of Bosuvi 400mg Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Bosuvi 400mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Bosuvi 400mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 400mg Bosuvi tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Bosuvi 400mg Tablet:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Cough
- Low blood platelets
- Anemia (low number of red blood cells)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Respiratory tract infection
- Decreased white blood cell count (neutrophils)
- Breathlessness
- Increased liver enzymes
How to use Bosuvi 400mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 400mg Bosuvi tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Bosuvi 400mg Tablet works:
Bosuvi 400mg tablets function as a tyrosine kinase inhibitor, a medication employed in cancer treatment. Its mechanism involves inhibiting the activity of aberrant proteins driving cancer proliferation and metastasis, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bosuvi 400mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Bosuvi 400mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing it is uncommon, reserved only for life-threatening conditions where potential benefits outweigh the dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Bosuvi 400mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Bosuvi 400mg Tablet on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Bosuvi 400mg tablets, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Bosuvi 400mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bosuvi 400mg Tablet :
Omit any missed Bosuvi 400mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bosuvi 400mg Tablet
| Label | Value |
|---|---|
| Chemical Category | 4-Aminoquinoline derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Behavioral Class | TKIs (Tyrosine Kinase Inhibitors) |

